1
|
Urquhart R, Adams M, Chakraborty S, Burns JC. Real Talk: Conversations on HIV with Black Heterosexual Men in Healthcare Settings. J Community Health 2024:10.1007/s10900-024-01388-9. [PMID: 39126616 DOI: 10.1007/s10900-024-01388-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 08/01/2024] [Indexed: 08/12/2024]
Abstract
Nearly half of heterosexually transmitted human immunodeficiency virus (HIV) infections occur among Black men in the United States. Yet Black heterosexual men (BHM) are largely ignored in HIV programming, policy implementation, and research. This study explores how masculinity, mental health, and socioeconomic factors such as income, education, and insurance (e.g., enrollment and coverage) correlate with the likelihood of BHM having important conversations surrounding HIV with their healthcare providers and family members. Conversations among social networks (e.g., peers, family, and neighbors) create an opportunity to increase comfortability while discussing HIV-related topics around condom use and testing. This study used a cross-sectional survey design and convenience sampling (N = 279) to recruit participants from a community-academic partnership involving a Federally Qualified Health Center (FQHC) in Detroit between June 1, 2020, and July 31, 2020. Descriptive statistics were used to report demographics, socioeconomic information, and sexual health-related behavior variables. Spearman's correlation test was used to report bivariate correlations between predictor and outcome variables. 49.3% of the study participants disclosed having ever talked to a healthcare provider about HIV/acquired immune deficiency syndrome (AIDS), and 40.9% disclosed having ever talked to a family member about HIV/AIDS and sexually transmitted infections (STIs). The results from this article highlight potential barriers that may inhibit BHM from engaging in conversations about HIV with their healthcare providers and family members. It is important to include BHM in future research that focuses on HIV prevention and education to support community leaders and clinicians who work to address these disparities.
Collapse
Affiliation(s)
- Rakira Urquhart
- School of Health and Human Sciences, University of North Carolina at Greensboro, 1408 Walker Ave 437 Coleman Bldg, Greensboro, NC, 27412, USA.
| | - Mackenzie Adams
- School of Public Health, University of Michigan, 1415 Washington Heights, Ann Arbor, MI, 48109, USA
| | - Shawtaabdee Chakraborty
- College of Human Medicine, Michigan State University, 15 Michigan St, NE Grand Rapids, MI, 49503, USA
| | - Jade C Burns
- School of Nursing, University of Michigan, 400 North Ingalls Street Room 3175, 400 NIB, Ann Arbor, MI, 48109, USA
| |
Collapse
|
2
|
Guiraud V, Beaulieu Q, Fauchois A, Jean-Charles P, Costes MC, Labousse BL, Gautheret-Dejean PA. Rapid tests should be used with caution for HIV-1 primary infection screening. Med Microbiol Immunol 2024; 213:10. [PMID: 38907945 DOI: 10.1007/s00430-024-00792-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/04/2023] [Accepted: 06/05/2024] [Indexed: 06/24/2024]
Abstract
Rapid tests allow outpatient, low cost, reliable, screening for chronic HIV infection. However, data regarding their sensitivity on primary infection remain scarce. The objective of this study was to assess sensitivity of nine HIV rapid tests for primary HIV-1 infection screening. Seventy-five serum samples from patients during HIV-1 primary infection were included. Primary infection was diagnosed by a positive 4th generation ELISA and HIV-1 RNA positivity confirmed by Western blot patterns associated with HIV-1 primary infection. Early seroconversion was defined as the absence of antibodies on HIV-1 Western blot associated with HIV-1 RNA and p24-antigen positivity. An identical sensitivity (95% CI) of 76.7% (65.2-84.2%) was observed for HIV 1/2 STAT-PAK® Assay (STAT-PAK), INSTI™ HIV-1/HIV-2 antibody Test (INSTI), SURE CHECK® HIV 1/2 (SURE CHECK) and MULTISURE HIV rapid test (MULTISURE) with visual reading. Sensitivity was 74.7% (63.8-83.1%) for MULTISURE (automatic reading), 77.0% (66.3-85.1%) for FIRST RESPONSE® Test VIH 1-2.O CARTE (FIRST RESPONSE), 83.8% (73.8-90.5%) for VIKIA HIV1/2® (VIKIA), 88.0% (78.7-93.6%) for Genie™ Fast HIV 1/2 (Genie Fast), 88.6% (79.0-94.1%) for Hexagon HIV (Hexagon), and 92.8% (83.6-96.3%) for Exacto® TEST HIV Pro (Exacto). However, rapid tests performed poorly for the early seroconversion subgroup (n = 14), with sensitivities ranging from 7% (1.3-31.5%) for STAT-PAK, INSTI, SURE CHECK, MULTISURE (automatic reading), to 29% (12-55%) for FIRST RESPONSE, 31% (13-58%) for VIKIA, 43% (21-67%) for Hexagon and 57.1% (32.6-78.6%) for Exacto and Genie Fast. Overall, despite significant discrepancies in sensitivity, HIV rapid tests should be used with caution in the context of a suspected primary infection.
Collapse
Affiliation(s)
- Vincent Guiraud
- Service de Virologie, AP-HP, Hôpitaux Universitaires La Pitié Salpêtrière-Charles Foix, Paris, F- 75013, France
| | - Quentin Beaulieu
- Service de Virologie, AP-HP, Hôpitaux Universitaires La Pitié Salpêtrière-Charles Foix, Paris, F- 75013, France
| | - Antoine Fauchois
- Service de Virologie, AP-HP, Hôpitaux Universitaires La Pitié Salpêtrière-Charles Foix, Paris, F- 75013, France
| | - Pascale Jean-Charles
- Service de Virologie, AP-HP, Hôpitaux Universitaires La Pitié Salpêtrière-Charles Foix, Paris, F- 75013, France
| | - Marie-Capucine Costes
- Service de Virologie, AP-HP, Hôpitaux Universitaires La Pitié Salpêtrière-Charles Foix, Paris, F- 75013, France
| | - Bruno Le Labousse
- Service de Virologie, AP-HP, Hôpitaux Universitaires La Pitié Salpêtrière-Charles Foix, Paris, F- 75013, France
| | - Pr Agnès Gautheret-Dejean
- Service de Virologie, AP-HP, Hôpitaux Universitaires La Pitié Salpêtrière-Charles Foix, Paris, F- 75013, France.
- Université Paris cité, INSERM UMR-S 1139 Physiopathologie et pharmacotoxicologie placentaire humaine : microbiote pré & post-natal, Paris, F-75006, France.
| |
Collapse
|
3
|
Forrester N, Keyes JZS, Cajimat R, Burklin Y, Hall MAK, Cobb J. Undiagnosed HIV in Patients on Immunosuppressive Medications Presenting with HIV-Associated Kidney Disease. South Med J 2024; 117:254-259. [PMID: 38701846 DOI: 10.14423/smj.0000000000001688] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/05/2024]
Abstract
Approximately 158,500 adults and adolescents in the United States live with undiagnosed human immunodeficiency virus (HIV). Missed or delayed diagnoses adversely affect disease management and outcomes. This is particularly salient for patients receiving immunosuppressive and immunomodulatory therapy for the management of chronic inflammatory conditions, in which additional immunosuppression may increase the risk and severity of opportunistic infections. Despite this risk, comprehensive HIV testing before the initiation of immunosuppressive therapy is not yet the norm. We describe a case series containing the narratives of three patients recently treated with immunosuppressive agents, who presented with signs concerning for HIV-associated kidney diseases and who were found to have undiagnosed HIV later in the treatment course, which, unfortunately, resulted in poor outcomes. Screening for HIV or related illnesses, such as viral hepatitis or mycobacterial co-infections including tuberculosis, is essential before initiating biologic immunosuppression.
Collapse
Affiliation(s)
| | | | | | | | | | - Jason Cobb
- Division of Renal Medicine, Emory University School of Medicine, Atlanta, Georgia
| |
Collapse
|
4
|
Abrantes R, Pimentel V, Miranda MNS, Silva AR, Diniz A, Ascenção B, Piñeiro C, Koch C, Rodrigues C, Caldas C, Morais C, Faria D, Gomes da Silva E, Teófilo E, Monteiro F, Roxo F, Maltez F, Rodrigues F, Gaião G, Ramos H, Costa I, Germano I, Simões J, Oliveira J, Ferreira J, Poças J, Saraiva da Cunha J, Soares J, Fernandes S, Mansinho K, Pedro L, Aleixo MJ, Gonçalves MJ, Manata MJ, Mouro M, Serrado M, Caixeiro M, Marques N, Costa O, Pacheco P, Proença P, Rodrigues P, Pinho R, Tavares R, Correia de Abreu R, Côrte-Real R, Serrão R, Sarmento e Castro R, Nunes S, Faria T, Baptista T, Simões D, Mendão L, Martins MRO, Gomes P, Pingarilho M, Abecasis AB. Determinants of HIV late presentation among men who have sex with men in Portugal (2014-2019): who's being left behind? Front Public Health 2024; 12:1336845. [PMID: 38500732 PMCID: PMC10947991 DOI: 10.3389/fpubh.2024.1336845] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/11/2023] [Accepted: 01/26/2024] [Indexed: 03/20/2024] Open
Abstract
Introduction HIV late presentation (LP) remains excessive in Europe. We aimed to analyze the factors associated with late presentation in the MSM population newly diagnosed with HIV in Portugal between 2014 and 2019. Methods We included 391 newly HIV-1 diagnosed Men who have Sex with Men (MSM), from the BESTHOPE project, in 17 countrywide Portuguese hospitals. The data included clinical and socio-behavioral questionnaires and the viral genomic sequence obtained in the drug resistance test before starting antiretrovirals (ARVs). HIV-1 subtypes and epidemiological surveillance mutations were determined using different bioinformatics tools. Logistic regression was used to estimate the association between predictor variables and late presentation (LP). Results The median age was 31 years, 51% had a current income between 501-1,000 euros, 28% were migrants. 21% had never been tested for HIV before diagnosis, with 42.3% of MSM presenting LP. 60% were infected with subtype B strains. In the multivariate regression, increased age at diagnosis, higher income, lower frequency of screening, STI ever diagnosed and higher viral load were associated with LP. Conclusion Our study suggests that specific subgroups of the MSM population, such older MSM, with higher income and lower HIV testing frequency, are not being targeted by community and clinical screening services. Overall, targeted public health measures should be strengthened toward these subgroups, through strengthened primary care testing, expanded access to PrEP, information and promotion of HIV self-testing and more inclusive and accessible health services.
Collapse
Affiliation(s)
- Ricardo Abrantes
- Global Health and Tropical Medicine (GHTM), Associate Laboratory in Translation and Innovation Towards Global Health (LA-REAL), Institute of Hygiene and Tropical Medicine, NOVA University of Lisbon (IHMT/UNL), Lisbon, Portugal
| | - Victor Pimentel
- Global Health and Tropical Medicine (GHTM), Associate Laboratory in Translation and Innovation Towards Global Health (LA-REAL), Institute of Hygiene and Tropical Medicine, NOVA University of Lisbon (IHMT/UNL), Lisbon, Portugal
| | - Mafalda N. S. Miranda
- Global Health and Tropical Medicine (GHTM), Associate Laboratory in Translation and Innovation Towards Global Health (LA-REAL), Institute of Hygiene and Tropical Medicine, NOVA University of Lisbon (IHMT/UNL), Lisbon, Portugal
| | - Ana Rita Silva
- Serviço de Infeciologia, Hospital Beatriz Ângelo, Loures, Portugal
| | - António Diniz
- U. Imunodeficiência, Hospital Pulido Valente, Centro Hospitalar Universitário de Lisboa Norte, Lisbon, Portugal
| | - Bianca Ascenção
- Serviço de Infeciologia, Centro Hospitalar de Setúbal, Setúbal, Portugal
| | - Carmela Piñeiro
- Serviço de Doenças Infeciosas, Centro Hospitalar Universitário de São João, Porto, Portugal
| | - Carmo Koch
- Centro de Biologia Molecular, Serviço de Imunohemoterapia do Centro Hospitalar Universitário de São João, Porto, Portugal
| | - Catarina Rodrigues
- Serviço de Medicina 1.4, Hospital de São José, Centro Hospitalar Universitário de Lisboa Central, Lisbon, Portugal
| | - Cátia Caldas
- Serviço de Doenças Infeciosas, Centro Hospitalar Universitário de São João, Porto, Portugal
| | - Célia Morais
- Serviço de Patologia Clínica, Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal
| | - Domitília Faria
- Serviço de Medicina 3, Hospital de Portimão, Centro Hospitalar Universitário do Algarve, Portimão, Portugal
| | | | - Eugénio Teófilo
- Serviço de Medicina 2.3, Hospital de Santo António dos Capuchos, Centro Hospitalar de Lisboa Central, Lisbon, Portugal
| | - Fátima Monteiro
- Centro de Biologia Molecular, Serviço de Imunohemoterapia do Centro Hospitalar Universitário de São João, Porto, Portugal
| | - Fausto Roxo
- Hospital de Dia de Doenças Infeciosas, Hospital Distrital de Santarém, Santarém, Portugal
| | - Fernando Maltez
- Serviço de Doenças Infeciosas, Hospital Curry Cabral, Centro Hospitalar de Lisboa, Lisbon, Portugal
| | - Fernando Rodrigues
- Serviço de Patologia Clínica, Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal
| | - Guilhermina Gaião
- Serviço de Patologia Clínica, Hospital de Sta Maria, Centro Hospitalar Universitário de Lisboa Norte, Lisbon, Portugal
| | - Helena Ramos
- Serviço de Patologia Clínica, Centro Hospitalar do Porto, Porto, Portugal
| | - Inês Costa
- Laboratório de Biologia Molecular (LMCBM, SPC, CHLO-HEM), Lisbon, Portugal
| | - Isabel Germano
- Serviço de Medicina 1.4, Hospital de São José, Centro Hospitalar Universitário de Lisboa Central, Lisbon, Portugal
| | - Joana Simões
- Serviço de Medicina 1.4, Hospital de São José, Centro Hospitalar Universitário de Lisboa Central, Lisbon, Portugal
| | - Joaquim Oliveira
- Serviço de Infeciologia, Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal
| | - José Ferreira
- Serviço de Medicina 2, Hospital de Faro, Centro Hospitalar Universitário do Algarve, Faro, Portugal
| | - José Poças
- Serviço de Infeciologia, Centro Hospitalar de Setúbal, Setúbal, Portugal
| | - José Saraiva da Cunha
- Serviço de Infeciologia, Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal
| | - Jorge Soares
- Serviço de Doenças Infeciosas, Centro Hospitalar Universitário de São João, Porto, Portugal
| | - Sandra Fernandes
- Laboratório de Biologia Molecular (LMCBM, SPC, CHLO-HEM), Lisbon, Portugal
| | - Kamal Mansinho
- Serviço de Doenças Infeciosas, Hospital de Egas Moniz, Centro Hospitalar de Lisboa Ocidental, Lisbon, Portugal
| | - Liliana Pedro
- Serviço de Medicina 3, Hospital de Portimão, Centro Hospitalar Universitário do Algarve, Portimão, Portugal
| | | | | | - Maria José Manata
- Serviço de Doenças Infeciosas, Hospital Curry Cabral, Centro Hospitalar de Lisboa, Lisbon, Portugal
| | - Margarida Mouro
- Serviço de Infeciologia, Hospital de Aveiro, Centro Hospitalar Baixo Vouga, Aveiro, Portugal
| | - Margarida Serrado
- U. Imunodeficiência, Hospital Pulido Valente, Centro Hospitalar Universitário de Lisboa Norte, Lisbon, Portugal
| | - Micaela Caixeiro
- Serviço de Infeciologia, Hospital Dr. Fernando da Fonseca, Amadora, Portugal
| | - Nuno Marques
- Serviço de Infeciologia, Hospital Garcia da Orta, Almada, Portugal
| | - Olga Costa
- Serviço de Patologia Clínica, Biologia Molecular, Centro Hospitalar Universitário de Lisboa Central, Lisbon, Portugal
| | - Patrícia Pacheco
- Serviço de Infeciologia, Hospital Dr. Fernando da Fonseca, Amadora, Portugal
| | - Paula Proença
- Serviço de Infeciologia, Hospital de Faro, Centro Hospitalar Universitário do Algarve, Faro, Portugal
| | - Paulo Rodrigues
- Serviço de Infeciologia, Hospital Beatriz Ângelo, Loures, Portugal
| | - Raquel Pinho
- Serviço de Medicina 3, Hospital de Portimão, Centro Hospitalar Universitário do Algarve, Portimão, Portugal
| | - Raquel Tavares
- Serviço de Infeciologia, Hospital Beatriz Ângelo, Loures, Portugal
| | - Ricardo Correia de Abreu
- Serviço de Infeciologia, Unidade de Local de Saúde de Matosinhos, Hospital Pedro Hispano, Matosinhos, Portugal
| | - Rita Côrte-Real
- Serviço de Patologia Clínica, Biologia Molecular, Centro Hospitalar Universitário de Lisboa Central, Lisbon, Portugal
| | - Rosário Serrão
- Serviço de Doenças Infeciosas, Centro Hospitalar Universitário de São João, Porto, Portugal
| | | | - Sofia Nunes
- Serviço de Infeciologia, Hospital de Aveiro, Centro Hospitalar Baixo Vouga, Aveiro, Portugal
| | - Telo Faria
- Unidade Local de Saúde do Baixo Alentejo, Hospital José Joaquim Fernandes, Beja, Portugal
| | - Teresa Baptista
- Serviço de Doenças Infeciosas, Hospital de Egas Moniz, Centro Hospitalar de Lisboa Ocidental, Lisbon, Portugal
| | - Daniel Simões
- Grupo de Ativistas em Tratamentos (GAT), Lisbon, Portugal
| | - Luis Mendão
- Grupo de Ativistas em Tratamentos (GAT), Lisbon, Portugal
| | - M. Rosário O. Martins
- Global Health and Tropical Medicine (GHTM), Associate Laboratory in Translation and Innovation Towards Global Health (LA-REAL), Institute of Hygiene and Tropical Medicine, NOVA University of Lisbon (IHMT/UNL), Lisbon, Portugal
| | - Perpétua Gomes
- Laboratório de Biologia Molecular (LMCBM, SPC, CHLO-HEM), Lisbon, Portugal
- Egas Moniz Center for Interdisciplinary Research (CiiEM), Egas Moniz School of Health & Science, Almada, Portugal
| | - Marta Pingarilho
- Global Health and Tropical Medicine (GHTM), Associate Laboratory in Translation and Innovation Towards Global Health (LA-REAL), Institute of Hygiene and Tropical Medicine, NOVA University of Lisbon (IHMT/UNL), Lisbon, Portugal
| | - Ana B. Abecasis
- Global Health and Tropical Medicine (GHTM), Associate Laboratory in Translation and Innovation Towards Global Health (LA-REAL), Institute of Hygiene and Tropical Medicine, NOVA University of Lisbon (IHMT/UNL), Lisbon, Portugal
| | | |
Collapse
|
5
|
Abu-Ba’are GR, Aidoo-Frimpong G, Stockton M, Zigah EY, Amuah S, Amu-Adu P, Amoh-Otoo RP, Nyblade L, Torpey K, Nelson LE. "I told myself, be bold and go and test": Motivators and barriers to HIV testing among gay, bisexual, and other cis-gender men who have sex with men in Ghana ‒ West Africa. PLOS GLOBAL PUBLIC HEALTH 2024; 4:e0002231. [PMID: 38206889 PMCID: PMC10783711 DOI: 10.1371/journal.pgph.0002231] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 03/15/2023] [Accepted: 11/17/2023] [Indexed: 01/13/2024]
Abstract
Despite a disproportionately high burden of HIV, GBMSM in Ghana and sub-Saharan Africa often delay testing until the point of illness. However, limited studies examine factors that affect their participation in testing. We used qualitative in-depth interviews (IDIs) and focus group discussions (FGDs) to collect insights into experiences, motivators, and barriers to HIV testing among GBMSM. Two community-based organizations used snowball and convenience sampling to recruit 10 GBMSM for IDIs and 8 to 12 for FGDs. We transcribed, coded, identified, and analyzed the relationship and commonalities between the participants' responses. Under experiences with testing, 1) fear of HIV infection created a stressful HIV testing experience, and 2) a friendly and supportive healthcare environment facilitated a positive experience in healthcare facilities. Motivators or facilitators of testing include 1) the perception or belief that HIV testing is an HIV prevention strategy; 2) encouragement from friends and peers; 3) understanding risk associated with certain sexual behaviors; 4) education or information on HIV; 5) access to free testing and incentives; 6) early symptoms and provider recommendation. Barriers to HIV testing include 1) negative community perceptions of HIV; 2) individual-level low-risk perception or indifference about HIV infection; 3) health system issues; 5) Perceived stigma at healthcare facilities. The findings point to the need to address critical issues around stigma, education, peer support, and healthcare resources through interventions and research to improve HIV testing among GBMSM in the country.
Collapse
Affiliation(s)
- Gamji Rabiu Abu-Ba’are
- Behavioral, Sexual and Global Health Lab, School of Nursing, University of Rochester Medical Center, University of Rochester, Rochester, New York, United States of America
- Department of Public Health Sciences, University of Rochester Medical Center, University of Rochester, Rochester, New York, United States of America
- Yale AIDS Prevention Program (Y-APT), Center for Interdisciplinary Research on AIDS, School of Public Health/Medicine, Yale University, New Haven, Connecticut, United States of America
- Behavioral, Sexual and Global Health Lab, West Africa Site, Jama’a Action, West Legon, Accra, Ghana
| | - Gloria Aidoo-Frimpong
- Yale AIDS Prevention Program (Y-APT), Center for Interdisciplinary Research on AIDS, School of Public Health/Medicine, Yale University, New Haven, Connecticut, United States of America
| | - Melissa Stockton
- Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America
| | - Edem Yaw Zigah
- Behavioral, Sexual and Global Health Lab, West Africa Site, Jama’a Action, West Legon, Accra, Ghana
- Priorities on Rights and Sexual Health, Accra, Ghana
| | - Samuel Amuah
- Youth Alliance for Health and Human Rights, Kumasi, Ghana
| | | | | | - Laura Nyblade
- RTI International, Washington, District of Columbia, United States of America
| | - Kwasi Torpey
- Department of Population, Family & Reproductive Health, School of Public Health, University of Ghana, Legon-Accra, Ghana
| | - LaRon E. Nelson
- Yale AIDS Prevention Program (Y-APT), Center for Interdisciplinary Research on AIDS, School of Public Health/Medicine, Yale University, New Haven, Connecticut, United States of America
- School of Nursing, Yale University, New Haven, Connecticut, United States of America
| |
Collapse
|
6
|
Kimball AA, Zhu W, Yu L, Tanner MR, Iqbal K, Dominguez KL, Shankar A, Drezner K, Musgrove K, Mayes E, Robinson WT, Schumacher C, Delaney KP, Hoover KW. Benefits of Frequent HIV Testing in the THRIVE Demonstration Project: United States, 2015-2020. Am J Public Health 2023; 113:1019-1027. [PMID: 37410983 PMCID: PMC10413751 DOI: 10.2105/ajph.2023.307341] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 05/16/2023] [Indexed: 07/08/2023]
Abstract
Objectives. To describe HIV testing among clients in the Targeted Highly Effective Interventions to Reverse the HIV Epidemic (THRIVE) demonstration project and evaluate testing frequency. Methods. We identified factors associated with an average testing frequency of 180 days or less compared with more than 180 days using adjusted Poisson regression models. We performed the Kaplan-Meier survival analysis to compare time to diagnosis by testing frequency. Results. Among 5710 clients with 2 or more tests and no preexposure prophylaxis (PrEP) prescription, 42.4% were tested frequently. Black/African American clients were 21% less likely and Hispanic/Latino clients were 18% less likely to be tested frequently than were White clients. Among 71 Black/African American and Hispanic/Latino cisgender men who have sex with men and transgender women with HIV diagnoses, those with frequent testing had a median time to diagnosis of 137 days, with a diagnostic testing yield of 1.5% compared with those tested less frequently, with 559 days and 0.8% yield. Conclusions. HIV testing at least every 6 months resulted in earlier HIV diagnosis and was efficient. Persons in communities with high rates of HIV who are not on PrEP can benefit from frequent testing, and collaborative community approaches may help reduce disparities. (Am J Public Health. 2023;113(9):1019-1027. https://doi.org/10.2105/AJPH.2023.307341).
Collapse
Affiliation(s)
- Anne A Kimball
- Anne A. Kimball, Weiming Zhu, Mary R. Tanner, Kashif Iqbal, Kenneth L. Dominguez, Kevin P. Delaney, and Karen W. Hoover are with the Division of HIV Prevention, Centers for Disease Control and Prevention, Atlanta, GA. Lei Yu is with the DLH Corporation, Atlanta. Aparna Shankar is with the New York City Department of Health and Mental Hygiene, New York, NY. Kate Drezner is with the District of Columbia Department of Health, Washington, DC. Karen Musgrove is with Birmingham AIDS Outreach, Birmingham, AL. Eric Mayes is with the Virginia Department of Health, Richmond. William T. Robinson is with the Louisiana Office of Public Health and Louisiana State University Health Sciences Center, New Orleans. Christina Schumacher is with the Center for Child and Community Health Research, Johns Hopkins School of Medicine, Baltimore, MD
| | - Weiming Zhu
- Anne A. Kimball, Weiming Zhu, Mary R. Tanner, Kashif Iqbal, Kenneth L. Dominguez, Kevin P. Delaney, and Karen W. Hoover are with the Division of HIV Prevention, Centers for Disease Control and Prevention, Atlanta, GA. Lei Yu is with the DLH Corporation, Atlanta. Aparna Shankar is with the New York City Department of Health and Mental Hygiene, New York, NY. Kate Drezner is with the District of Columbia Department of Health, Washington, DC. Karen Musgrove is with Birmingham AIDS Outreach, Birmingham, AL. Eric Mayes is with the Virginia Department of Health, Richmond. William T. Robinson is with the Louisiana Office of Public Health and Louisiana State University Health Sciences Center, New Orleans. Christina Schumacher is with the Center for Child and Community Health Research, Johns Hopkins School of Medicine, Baltimore, MD
| | - Lei Yu
- Anne A. Kimball, Weiming Zhu, Mary R. Tanner, Kashif Iqbal, Kenneth L. Dominguez, Kevin P. Delaney, and Karen W. Hoover are with the Division of HIV Prevention, Centers for Disease Control and Prevention, Atlanta, GA. Lei Yu is with the DLH Corporation, Atlanta. Aparna Shankar is with the New York City Department of Health and Mental Hygiene, New York, NY. Kate Drezner is with the District of Columbia Department of Health, Washington, DC. Karen Musgrove is with Birmingham AIDS Outreach, Birmingham, AL. Eric Mayes is with the Virginia Department of Health, Richmond. William T. Robinson is with the Louisiana Office of Public Health and Louisiana State University Health Sciences Center, New Orleans. Christina Schumacher is with the Center for Child and Community Health Research, Johns Hopkins School of Medicine, Baltimore, MD
| | - Mary R Tanner
- Anne A. Kimball, Weiming Zhu, Mary R. Tanner, Kashif Iqbal, Kenneth L. Dominguez, Kevin P. Delaney, and Karen W. Hoover are with the Division of HIV Prevention, Centers for Disease Control and Prevention, Atlanta, GA. Lei Yu is with the DLH Corporation, Atlanta. Aparna Shankar is with the New York City Department of Health and Mental Hygiene, New York, NY. Kate Drezner is with the District of Columbia Department of Health, Washington, DC. Karen Musgrove is with Birmingham AIDS Outreach, Birmingham, AL. Eric Mayes is with the Virginia Department of Health, Richmond. William T. Robinson is with the Louisiana Office of Public Health and Louisiana State University Health Sciences Center, New Orleans. Christina Schumacher is with the Center for Child and Community Health Research, Johns Hopkins School of Medicine, Baltimore, MD
| | - Kashif Iqbal
- Anne A. Kimball, Weiming Zhu, Mary R. Tanner, Kashif Iqbal, Kenneth L. Dominguez, Kevin P. Delaney, and Karen W. Hoover are with the Division of HIV Prevention, Centers for Disease Control and Prevention, Atlanta, GA. Lei Yu is with the DLH Corporation, Atlanta. Aparna Shankar is with the New York City Department of Health and Mental Hygiene, New York, NY. Kate Drezner is with the District of Columbia Department of Health, Washington, DC. Karen Musgrove is with Birmingham AIDS Outreach, Birmingham, AL. Eric Mayes is with the Virginia Department of Health, Richmond. William T. Robinson is with the Louisiana Office of Public Health and Louisiana State University Health Sciences Center, New Orleans. Christina Schumacher is with the Center for Child and Community Health Research, Johns Hopkins School of Medicine, Baltimore, MD
| | - Kenneth L Dominguez
- Anne A. Kimball, Weiming Zhu, Mary R. Tanner, Kashif Iqbal, Kenneth L. Dominguez, Kevin P. Delaney, and Karen W. Hoover are with the Division of HIV Prevention, Centers for Disease Control and Prevention, Atlanta, GA. Lei Yu is with the DLH Corporation, Atlanta. Aparna Shankar is with the New York City Department of Health and Mental Hygiene, New York, NY. Kate Drezner is with the District of Columbia Department of Health, Washington, DC. Karen Musgrove is with Birmingham AIDS Outreach, Birmingham, AL. Eric Mayes is with the Virginia Department of Health, Richmond. William T. Robinson is with the Louisiana Office of Public Health and Louisiana State University Health Sciences Center, New Orleans. Christina Schumacher is with the Center for Child and Community Health Research, Johns Hopkins School of Medicine, Baltimore, MD
| | - Aparna Shankar
- Anne A. Kimball, Weiming Zhu, Mary R. Tanner, Kashif Iqbal, Kenneth L. Dominguez, Kevin P. Delaney, and Karen W. Hoover are with the Division of HIV Prevention, Centers for Disease Control and Prevention, Atlanta, GA. Lei Yu is with the DLH Corporation, Atlanta. Aparna Shankar is with the New York City Department of Health and Mental Hygiene, New York, NY. Kate Drezner is with the District of Columbia Department of Health, Washington, DC. Karen Musgrove is with Birmingham AIDS Outreach, Birmingham, AL. Eric Mayes is with the Virginia Department of Health, Richmond. William T. Robinson is with the Louisiana Office of Public Health and Louisiana State University Health Sciences Center, New Orleans. Christina Schumacher is with the Center for Child and Community Health Research, Johns Hopkins School of Medicine, Baltimore, MD
| | - Kate Drezner
- Anne A. Kimball, Weiming Zhu, Mary R. Tanner, Kashif Iqbal, Kenneth L. Dominguez, Kevin P. Delaney, and Karen W. Hoover are with the Division of HIV Prevention, Centers for Disease Control and Prevention, Atlanta, GA. Lei Yu is with the DLH Corporation, Atlanta. Aparna Shankar is with the New York City Department of Health and Mental Hygiene, New York, NY. Kate Drezner is with the District of Columbia Department of Health, Washington, DC. Karen Musgrove is with Birmingham AIDS Outreach, Birmingham, AL. Eric Mayes is with the Virginia Department of Health, Richmond. William T. Robinson is with the Louisiana Office of Public Health and Louisiana State University Health Sciences Center, New Orleans. Christina Schumacher is with the Center for Child and Community Health Research, Johns Hopkins School of Medicine, Baltimore, MD
| | - Karen Musgrove
- Anne A. Kimball, Weiming Zhu, Mary R. Tanner, Kashif Iqbal, Kenneth L. Dominguez, Kevin P. Delaney, and Karen W. Hoover are with the Division of HIV Prevention, Centers for Disease Control and Prevention, Atlanta, GA. Lei Yu is with the DLH Corporation, Atlanta. Aparna Shankar is with the New York City Department of Health and Mental Hygiene, New York, NY. Kate Drezner is with the District of Columbia Department of Health, Washington, DC. Karen Musgrove is with Birmingham AIDS Outreach, Birmingham, AL. Eric Mayes is with the Virginia Department of Health, Richmond. William T. Robinson is with the Louisiana Office of Public Health and Louisiana State University Health Sciences Center, New Orleans. Christina Schumacher is with the Center for Child and Community Health Research, Johns Hopkins School of Medicine, Baltimore, MD
| | - Eric Mayes
- Anne A. Kimball, Weiming Zhu, Mary R. Tanner, Kashif Iqbal, Kenneth L. Dominguez, Kevin P. Delaney, and Karen W. Hoover are with the Division of HIV Prevention, Centers for Disease Control and Prevention, Atlanta, GA. Lei Yu is with the DLH Corporation, Atlanta. Aparna Shankar is with the New York City Department of Health and Mental Hygiene, New York, NY. Kate Drezner is with the District of Columbia Department of Health, Washington, DC. Karen Musgrove is with Birmingham AIDS Outreach, Birmingham, AL. Eric Mayes is with the Virginia Department of Health, Richmond. William T. Robinson is with the Louisiana Office of Public Health and Louisiana State University Health Sciences Center, New Orleans. Christina Schumacher is with the Center for Child and Community Health Research, Johns Hopkins School of Medicine, Baltimore, MD
| | - William T Robinson
- Anne A. Kimball, Weiming Zhu, Mary R. Tanner, Kashif Iqbal, Kenneth L. Dominguez, Kevin P. Delaney, and Karen W. Hoover are with the Division of HIV Prevention, Centers for Disease Control and Prevention, Atlanta, GA. Lei Yu is with the DLH Corporation, Atlanta. Aparna Shankar is with the New York City Department of Health and Mental Hygiene, New York, NY. Kate Drezner is with the District of Columbia Department of Health, Washington, DC. Karen Musgrove is with Birmingham AIDS Outreach, Birmingham, AL. Eric Mayes is with the Virginia Department of Health, Richmond. William T. Robinson is with the Louisiana Office of Public Health and Louisiana State University Health Sciences Center, New Orleans. Christina Schumacher is with the Center for Child and Community Health Research, Johns Hopkins School of Medicine, Baltimore, MD
| | - Christina Schumacher
- Anne A. Kimball, Weiming Zhu, Mary R. Tanner, Kashif Iqbal, Kenneth L. Dominguez, Kevin P. Delaney, and Karen W. Hoover are with the Division of HIV Prevention, Centers for Disease Control and Prevention, Atlanta, GA. Lei Yu is with the DLH Corporation, Atlanta. Aparna Shankar is with the New York City Department of Health and Mental Hygiene, New York, NY. Kate Drezner is with the District of Columbia Department of Health, Washington, DC. Karen Musgrove is with Birmingham AIDS Outreach, Birmingham, AL. Eric Mayes is with the Virginia Department of Health, Richmond. William T. Robinson is with the Louisiana Office of Public Health and Louisiana State University Health Sciences Center, New Orleans. Christina Schumacher is with the Center for Child and Community Health Research, Johns Hopkins School of Medicine, Baltimore, MD
| | - Kevin P Delaney
- Anne A. Kimball, Weiming Zhu, Mary R. Tanner, Kashif Iqbal, Kenneth L. Dominguez, Kevin P. Delaney, and Karen W. Hoover are with the Division of HIV Prevention, Centers for Disease Control and Prevention, Atlanta, GA. Lei Yu is with the DLH Corporation, Atlanta. Aparna Shankar is with the New York City Department of Health and Mental Hygiene, New York, NY. Kate Drezner is with the District of Columbia Department of Health, Washington, DC. Karen Musgrove is with Birmingham AIDS Outreach, Birmingham, AL. Eric Mayes is with the Virginia Department of Health, Richmond. William T. Robinson is with the Louisiana Office of Public Health and Louisiana State University Health Sciences Center, New Orleans. Christina Schumacher is with the Center for Child and Community Health Research, Johns Hopkins School of Medicine, Baltimore, MD
| | - Karen W Hoover
- Anne A. Kimball, Weiming Zhu, Mary R. Tanner, Kashif Iqbal, Kenneth L. Dominguez, Kevin P. Delaney, and Karen W. Hoover are with the Division of HIV Prevention, Centers for Disease Control and Prevention, Atlanta, GA. Lei Yu is with the DLH Corporation, Atlanta. Aparna Shankar is with the New York City Department of Health and Mental Hygiene, New York, NY. Kate Drezner is with the District of Columbia Department of Health, Washington, DC. Karen Musgrove is with Birmingham AIDS Outreach, Birmingham, AL. Eric Mayes is with the Virginia Department of Health, Richmond. William T. Robinson is with the Louisiana Office of Public Health and Louisiana State University Health Sciences Center, New Orleans. Christina Schumacher is with the Center for Child and Community Health Research, Johns Hopkins School of Medicine, Baltimore, MD
| |
Collapse
|
7
|
Hou W, Jiang H, Zhu Q, Huang J, Li J, Wu X, Liu X, Liang N, Tang S, Meng Q, Li B, Ding D, Chen N, Lan G. Characteristics of Migration Among HIV-Positive MSM - Guangxi Zhuang Autonomous Region, China, 2005-2021. China CDC Wkly 2023; 5:287-291. [PMID: 37139145 PMCID: PMC10150744 DOI: 10.46234/ccdcw2023.052] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/02/2022] [Accepted: 03/22/2023] [Indexed: 05/05/2023] Open
Abstract
What is already known about this topic? Migration has a significant impact on the transmission of human immunodeficiency virus (HIV). To date, there have been few studies examining the characteristics of migration among HIV-positive men who have sex with men (MSM). What is added by this report? The prevalence of migrants among newly reported HIV-positive MSM in Guangxi Zhuang Autonomous Region increased from 2005 to 2021. Yulin Prefecture had the highest proportion of out-migrant MSM (12.6%), while Nanning Prefecture had the highest proportion of in-migrant MSM (55.9%). Risk factors associated with migration among MSM included being in the 18-24 age range, having a college education or higher, and being a student. What are the implications for public health practice? A complex prefecture-level network of HIV-positive MSM exists in Guangxi. To ensure effective follow-up management and antiretroviral therapy for migrant MSM, effective measures must be taken.
Collapse
Affiliation(s)
- Wenxuan Hou
- Guangxi University of Chinese Medicine, Nanning City, Guangxi Zhuang Autonomous Region, China
| | - He Jiang
- Guangxi Key Laboratory of AIDS Prevention and Control and Achievement Transformation, Guangxi Center for Disease Prevention and Control, Nanning City, Guangxi Zhuang Autonomous Region, China
| | - Qiuying Zhu
- Guangxi Key Laboratory of AIDS Prevention and Control and Achievement Transformation, Guangxi Center for Disease Prevention and Control, Nanning City, Guangxi Zhuang Autonomous Region, China
| | - Jinghua Huang
- Guangxi Key Laboratory of AIDS Prevention and Control and Achievement Transformation, Guangxi Center for Disease Prevention and Control, Nanning City, Guangxi Zhuang Autonomous Region, China
| | - Jianjun Li
- Guangxi Key Laboratory of AIDS Prevention and Control and Achievement Transformation, Guangxi Center for Disease Prevention and Control, Nanning City, Guangxi Zhuang Autonomous Region, China
| | - Xiuling Wu
- Guangxi Key Laboratory of AIDS Prevention and Control and Achievement Transformation, Guangxi Center for Disease Prevention and Control, Nanning City, Guangxi Zhuang Autonomous Region, China
| | - Xuanhua Liu
- Guangxi Key Laboratory of AIDS Prevention and Control and Achievement Transformation, Guangxi Center for Disease Prevention and Control, Nanning City, Guangxi Zhuang Autonomous Region, China
| | - Nengxiu Liang
- Guangxi Key Laboratory of AIDS Prevention and Control and Achievement Transformation, Guangxi Center for Disease Prevention and Control, Nanning City, Guangxi Zhuang Autonomous Region, China
| | - Shuai Tang
- Guangxi Key Laboratory of AIDS Prevention and Control and Achievement Transformation, Guangxi Center for Disease Prevention and Control, Nanning City, Guangxi Zhuang Autonomous Region, China
| | - Qin Meng
- Guangxi Key Laboratory of AIDS Prevention and Control and Achievement Transformation, Guangxi Center for Disease Prevention and Control, Nanning City, Guangxi Zhuang Autonomous Region, China
| | - Bo Li
- Guangxi Key Laboratory of AIDS Prevention and Control and Achievement Transformation, Guangxi Center for Disease Prevention and Control, Nanning City, Guangxi Zhuang Autonomous Region, China
| | - Dongni Ding
- Guangxi Key Laboratory of AIDS Prevention and Control and Achievement Transformation, Guangxi Center for Disease Prevention and Control, Nanning City, Guangxi Zhuang Autonomous Region, China
| | - Ni Chen
- Guangxi Key Laboratory of AIDS Prevention and Control and Achievement Transformation, Guangxi Center for Disease Prevention and Control, Nanning City, Guangxi Zhuang Autonomous Region, China
- Youjiang Medical University for Nationalities, Baise City, Guangxi Zhuang Autonomous Region, China
| | - Guanghua Lan
- Guangxi University of Chinese Medicine, Nanning City, Guangxi Zhuang Autonomous Region, China
- Guangxi Key Laboratory of AIDS Prevention and Control and Achievement Transformation, Guangxi Center for Disease Prevention and Control, Nanning City, Guangxi Zhuang Autonomous Region, China
- Guanghua Lan,
| |
Collapse
|
8
|
Budzyńska J, Patryn R, Kozioł I, Leśniewska M, Kopystecka A, Skubel T. Self-Testing as a Hope to Reduce HIV in Transgender Women—Literature Review. INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH 2022; 19:ijerph19159331. [PMID: 35954695 PMCID: PMC9368376 DOI: 10.3390/ijerph19159331] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 06/19/2022] [Revised: 07/24/2022] [Accepted: 07/28/2022] [Indexed: 02/04/2023]
Abstract
So far, the rate of HIV-positive people who do not know their sero-status is about 14% and the percentage is higher among transgender women (TGW). They represent one of the most vulnerable groups to infection. HIV self-testing (HIVST) may be a way to reduce transmission of the virus. The aim of this analysis and in-depth review was to collect available data on factors that may influence the use and dissemination of HIVST among TGW. This review was conducted in accordance with PRISMA guidelines for systematic reviews and meta-analyses. All data from 48 papers were used. From the available literature, HIVST is a convenient and preferred method of testing due to its high confidentiality and possibility of being performed at home. However, there are barriers that limit its use, including marginalization of transgender people, stigma by medical personnel, lack of acceptance of sexual partners, and even cultural standards. Therefore, there is a need for activities that promote and inform on the possibility of using HIVST as well as enable easier access to it.
Collapse
Affiliation(s)
- Julia Budzyńska
- Students’ Scientific Group on Medical Law, Department of Humanities and Social Medicine, Medical University of Lublin, 20-059 Lublin, Poland; (I.K.); (M.L.); (A.K.); (T.S.)
- Correspondence:
| | - Rafał Patryn
- Department of Humanities and Social Medicine, Medical University of Lublin, 20-059 Lublin, Poland;
| | - Ilona Kozioł
- Students’ Scientific Group on Medical Law, Department of Humanities and Social Medicine, Medical University of Lublin, 20-059 Lublin, Poland; (I.K.); (M.L.); (A.K.); (T.S.)
| | - Magdalena Leśniewska
- Students’ Scientific Group on Medical Law, Department of Humanities and Social Medicine, Medical University of Lublin, 20-059 Lublin, Poland; (I.K.); (M.L.); (A.K.); (T.S.)
| | - Agnieszka Kopystecka
- Students’ Scientific Group on Medical Law, Department of Humanities and Social Medicine, Medical University of Lublin, 20-059 Lublin, Poland; (I.K.); (M.L.); (A.K.); (T.S.)
| | - Tomasz Skubel
- Students’ Scientific Group on Medical Law, Department of Humanities and Social Medicine, Medical University of Lublin, 20-059 Lublin, Poland; (I.K.); (M.L.); (A.K.); (T.S.)
| |
Collapse
|